Eli Lilly forecasts $45 billion revenue for 2024, 32% higher than last year. Medicare changes and stocking issues impact the revised guidance.
Eli Lilly's stock dipped due to cutting Q4 sales targets, despite a strong 2024 performance from Mounjaro and Zepbound. Click ...
The Biotech Ecosystem Venture Fund will combine the sourcing capabilities of venture capital firm Andreessen Horowitz (a16z) ...
The U.S. stock market experienced mixed results on Tuesday. The Dow Jones index climbed over 220 points to 42,518.28, while ...
Pharma major Eli Lilly and Company on Thursday said it plans to establish a new global capability centre in Hyderabad and ...
1d
Real-time index price for Nasdaq US Sm Cap Consumer Electronics Index (NQCE), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
Eli Lilly establishes new global capability centre in Hyderabad, recruiting over 1,000 skilled team members for digital ...
This latest news from Meta comes after the company last week announced it was ending its US fact-checking programme. The ...
Hyderabad: Eli Lilly and Company is planning to set up a new global capability centre in Hyderabad. This will be the ...
Lilly anticipates revenue growth contributions in 2025 from new Lilly medicines such as Jaypirca, Ebglyss, Omvoh and Kisunla; approvals of new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback